EFPIA - NEWSLETTER

EFPIA Newsletter 22 June 2017

WeWontRest

News

20 June 2017 20 June 2017 EFPIA Appoints New President and Vice Presidents

EFPIA is delighted to announce the appointment of three key roles on the EFPIA Board

20 June 2017 20 June 2017 Pharmaceutical companies continue to drive transparency and underline industry...

Over the next ten days, pharmaceutical companies will disclose details of collaborations with health professionals (HCPs)...

Illness never sleeps, so neither do we

WeWontRest

Illness never sleeps, and medical innovation needs to be one step ahead, so that breakthroughs can be made.

Events

28 JUN 2017

1 June 2017 EMIF: “Digital Citizen, Digital Patient” Tallinn, Estonia

This conference will inspire EU healthcare thought leaders to present research findings and share best practices on...

Learn more →

19 SEP 2017

The place of the Certification Procedure in the global regulatory environment Prague, Czech Republic

International Conference organised by the European Directorate for the Quality of Medicines & HealthCare (EDQM), Council...

Learn more →

What we are reading

EU innovation: some improvements but more even progress is needed 20 June 2017 (European Commission)

Time to act on Antibacterial resistance 16 June 2017 (The Parliament Magazine)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶